# ActiWhite (Skin Lightening Peptide)

**Canonical URL:** https://ingredients.hermeticasuperfoods.com/ingredients/actiwhite
**Data Source:** Hermetica Superfoods Ingredient Encyclopedia
**Updated:** 2026-04-03
**Evidence Score:** 2 / 10
**Category:** Other
**Also Known As:** Actiwhite PW LS 9860, Sucrose Dilaurate/Pisum Sativum Extract Complex, Pea Extract Skin Lightening Complex, BASF ActiWhite, Sucrose Dilaurate-Pea Extract Blend

## Overview

ActiWhite is a synthetic tetrapeptide (Acetyl Tetrapeptide-30) developed by Lipotec that inhibits melanin synthesis by targeting multiple steps in the melanogenesis pathway. It works primarily by downregulating tyrosinase activity and reducing the transfer of melanosomes from melanocytes to keratinocytes, resulting in progressive skin lightening.

## Health Benefits

• Lightens skin tone comparable to hydroquinone after 6 weeks of use (manufacturer-sponsored study, limited evidence quality)
• Reduces appearance of age spots and dark spots (manufacturer claims, limited clinical evidence)
• Exhibits high skin tolerance with no reported irritation in clinical testing (manufacturer-sponsored trials)
• Compatible with UV filters, AHAs, and vitamin C for comprehensive skincare (manufacturer data)
• Meets regulatory standards for Chinese and Japanese Quasi-Drug markets (regulatory approval evidence)

## Mechanism of Action

ActiWhite (Acetyl Tetrapeptide-30) inhibits melanogenesis through dual-pathway suppression: it downregulates tyrosinase, the rate-limiting enzyme in melanin biosynthesis, and also reduces expression of MITF (microphthalmia-associated transcription factor), the master regulator of melanocyte differentiation. Additionally, it impairs melanosome transfer to surrounding keratinocytes by interfering with PAR-2 (protease-activated receptor-2) signaling, which is a key receptor governing this intercellular pigment transfer process. These combined actions reduce both melanin production and its visible deposition in the skin.

## Clinical Summary

A manufacturer-sponsored in vitro study demonstrated that ActiWhite reduced melanin content in melanocyte cell cultures in a dose-dependent manner, with results compared favorably to hydroquinone at equivalent concentrations. A small clinical study (specific sample size not publicly disclosed by Lipotec) reported measurable lightening of skin tone and reduction in age spot intensity after 6 weeks of topical application at 2–5% concentration. Evidence quality is limited by the absence of large-scale, independent, double-blind, randomized controlled trials, and most published data originates from the manufacturer. No head-to-head peer-reviewed trials comparing ActiWhite directly to hydroquinone, kojic acid, or niacinamide have been independently published as of available literature.

## Nutritional Profile

ActiWhite is a synthetic cosmetic peptide ingredient, not a nutritional/food substance, and therefore has no conventional macronutrient or micronutrient profile. It is a topically applied active ingredient, not intended for ingestion. Compositionally, it is reported to contain a small oligopeptide (typically a short-chain amino acid sequence, likely 2-5 amino acids in length) as its primary bioactive compound, delivered in a carrier base. The peptide component constitutes a minor fraction of the formulation (typically 1-5% active peptide concentration in finished product formulations, per manufacturer usage guidelines). As a peptide, it is structurally composed of amino acid residues (specific sequence proprietary to manufacturer), contributing negligible caloric or nutritional value when used topically. No vitamins, dietary minerals, dietary fiber, or meaningful protein content is applicable in a nutritional context. Bioavailability in the nutritional sense is not relevant; however, dermal penetration is the functional delivery mechanism, with the peptide designed for transdermal absorption into the epidermis and upper dermis. No dietary reference intake (DRI) values apply. Any amino acid contribution from topical use is considered negligible from a systemic nutritional standpoint.

## Dosage & Preparation

Clinically studied dosage is 2% concentration in cosmetic formulations (emulsions, gels at pH 4-8), applied twice daily. Available as water-dispersible powder or liquid form, requiring water up to 80°C for proper solubility. Do not apply undiluted. Consult a healthcare provider before starting any new supplement.

## Safety & Drug Interactions

ActiWhite has demonstrated high cutaneous tolerance in available clinical testing, with no reports of irritation, sensitization, or allergic contact dermatitis in manufacturer-conducted studies, making it potentially suitable for sensitive skin types. No known systemic drug interactions have been identified, as topical absorption of peptides of this molecular size is generally low and systemic bioavailability is considered minimal. Safety data during pregnancy and lactation is not established due to the absence of clinical trials in these populations, and its use is generally not recommended during pregnancy as a precautionary measure. Individuals with known hypersensitivity to peptide-based cosmetic ingredients should perform a patch test prior to full application.

## Scientific Research

ActiWhite has undergone two manufacturer-sponsored clinical studies, though no independently published RCTs or meta-analyses were identified (no PubMed PMIDs available). In one study on Asian skin, twice-daily application at 2% concentration for 6 weeks showed skin lightening effects equivalent to hydroquinone with high tolerance and no irritation, though exact sample sizes were not specified.

## Historical & Cultural Context

No historical or traditional medicinal use is documented for ActiWhite, as it is a modern branded cosmetic complex developed through contemporary biotechnology. The ingredient has no ties to traditional medicine systems and represents a recent innovation in cosmetic skin care.

## Synergistic Combinations

UV filters, Alpha Hydroxy Acids (AHAs), Vitamin C, Niacinamide, Kojic Acid

## Frequently Asked Questions

### How does ActiWhite compare to hydroquinone for skin lightening?

A manufacturer-sponsored study claims ActiWhite (Acetyl Tetrapeptide-30) achieves comparable skin lightening to hydroquinone after approximately 6 weeks of use at concentrations of 2–5%. However, hydroquinone remains the gold standard with decades of independent clinical evidence, while ActiWhite lacks large-scale, peer-reviewed comparative trials. ActiWhite may offer an advantage in tolerability, as hydroquinone carries risks of ochronosis and irritation with long-term use.

### What concentration of ActiWhite is used in skincare formulations?

ActiWhite is typically formulated into topical skincare products at concentrations between 2% and 5% as recommended by its manufacturer, Lipotec. At these concentrations it has demonstrated tyrosinase inhibition and melanosome transfer reduction in in vitro models. The optimal effective concentration in real-world cosmetic use has not been independently validated through large-scale clinical trials.

### How long does ActiWhite take to show visible skin lightening results?

Based on manufacturer-conducted clinical data, visible improvements in skin tone and reduction in dark spot intensity are reported after approximately 6 weeks of consistent daily topical application. The mechanism — downregulating MITF transcription and tyrosinase enzyme activity — is gradual, as existing melanin must naturally shed through keratinocyte turnover before results are apparent. Individual results may vary based on skin type, baseline pigmentation, and formulation concentration.

### Is ActiWhite safe for sensitive skin?

Manufacturer-reported clinical tolerance studies indicate that ActiWhite produced no irritation, redness, or sensitization reactions in tested subjects, suggesting it is well-tolerated even on sensitive skin. Unlike alpha-arbutin or kojic acid, which can cause mild irritation in some users, the peptide structure of Acetyl Tetrapeptide-30 appears to have a low sensitization profile. However, independent dermatological safety assessments are limited, and a patch test is advisable before widespread use on reactive or sensitized skin.

### What is the active compound in ActiWhite and how is it classified?

The active compound in ActiWhite is Acetyl Tetrapeptide-30, a synthetically engineered tetrapeptide consisting of four amino acid residues with an acetyl group modification that enhances skin penetration and stability. It is classified as a signal peptide in cosmetic science, meaning it mimics or modulates biological signaling processes — in this case, pathways governing melanin synthesis and melanosome transfer. It is listed under the INCI (International Nomenclature of Cosmetic Ingredients) name Acetyl Tetrapeptide-30 and is a proprietary ingredient patented by Lipotec S.A.U.

### Can ActiWhite be used together with other skin-lightening ingredients like niacinamide or kojic acid?

ActiWhite is compatible with UV filters, AHAs, and vitamin C for comprehensive skincare regimens. However, combining multiple skin-lightening actives (such as kojic acid or niacinamide) may increase the risk of irritation or reduce efficacy due to competing mechanisms; it is advisable to consult a dermatologist before layering ActiWhite with other depigmenting agents.

### What is the current level of clinical evidence supporting ActiWhite's effectiveness compared to established skin-lightening ingredients?

Available evidence for ActiWhite is primarily from manufacturer-sponsored studies, which are considered lower quality compared to independent, peer-reviewed research. While the ingredient demonstrated skin lightening comparable to hydroquinone after 6 weeks in these trials, the limited and non-independent nature of the evidence means more rigorous third-party clinical studies are needed to establish robust safety and efficacy claims.

### Who is the ideal candidate for using ActiWhite, and are there groups who should avoid it?

ActiWhite is intended for individuals seeking to reduce dark spots, age spots, and uneven skin tone and has shown high skin tolerance with no reported irritation in clinical testing. Those with extremely sensitive skin, active dermatological conditions, or pregnant and nursing individuals should consult a healthcare provider before use, as safety data in these populations is limited.

---

*Source: Hermetica Superfoods Ingredient Encyclopedia — https://ingredients.hermeticasuperfoods.com*
*License: CC BY-NC-SA 4.0 — Attribution required. Commercial use: admin@hermeticasuperfoods.com*